全文获取类型
收费全文 | 2233篇 |
免费 | 165篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 30篇 |
妇产科学 | 12篇 |
基础医学 | 296篇 |
口腔科学 | 105篇 |
临床医学 | 124篇 |
内科学 | 575篇 |
皮肤病学 | 13篇 |
神经病学 | 110篇 |
特种医学 | 134篇 |
外科学 | 243篇 |
综合类 | 31篇 |
预防医学 | 109篇 |
眼科学 | 21篇 |
药学 | 293篇 |
中国医学 | 6篇 |
肿瘤学 | 303篇 |
出版年
2023年 | 19篇 |
2022年 | 22篇 |
2021年 | 50篇 |
2020年 | 29篇 |
2019年 | 46篇 |
2018年 | 48篇 |
2017年 | 50篇 |
2016年 | 47篇 |
2015年 | 48篇 |
2014年 | 55篇 |
2013年 | 73篇 |
2012年 | 104篇 |
2011年 | 121篇 |
2010年 | 54篇 |
2009年 | 44篇 |
2008年 | 89篇 |
2007年 | 104篇 |
2006年 | 77篇 |
2005年 | 84篇 |
2004年 | 88篇 |
2003年 | 70篇 |
2002年 | 76篇 |
2001年 | 87篇 |
2000年 | 79篇 |
1999年 | 82篇 |
1998年 | 30篇 |
1997年 | 40篇 |
1996年 | 11篇 |
1995年 | 14篇 |
1994年 | 16篇 |
1993年 | 12篇 |
1992年 | 66篇 |
1991年 | 67篇 |
1990年 | 58篇 |
1989年 | 47篇 |
1988年 | 41篇 |
1987年 | 40篇 |
1986年 | 53篇 |
1985年 | 58篇 |
1984年 | 30篇 |
1983年 | 25篇 |
1982年 | 13篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1974年 | 14篇 |
1973年 | 11篇 |
1970年 | 8篇 |
1968年 | 13篇 |
排序方式: 共有2413条查询结果,搜索用时 0 毫秒
51.
Kwan‐Lung Ko Wai‐Pan To Lung‐Yi Mak Wai‐Kay Seto Qin Ning James Fung Ching‐Lung Lai Man‐Fung Yuen 《Journal of viral hepatitis》2020,27(4):397-406
Real‐world studies examining reduction in risk of hepatocellular carcinoma (HCC) in patients receiving antivirals are limited by the small size of the studies, or by data insufficiency and heterogeneity with short follow‐up duration. We aimed to examine the real‐world long‐term outcome of patients receiving entecavir treatment on HCC incidence and HBsAg seroclearance. The incidence of HCC in 1225 entecavir‐treated patients between 2002 and 2015 was compared with the HCC incidence estimated using the REACH‐B, GAG‐HCC and CU‐HCC scores. Standardized incidence ratios (SIR) were calculated. The impact of entecavir treatment on HBsAg seroclearance was also explored. The median follow‐up of the cohort was 6.6 years, with 66 cases of HCC development. Using the REACH‐B model, the reduction of HCC risk was significant from year 6 onwards with SIR of 0.68 (95% CI 0.535‐0.866) at year 10. In subgroup patients without cirrhosis, consistent risk reduction was observed from the fifth year and the SIR reached 0.51 (95% CI 0.271‐0.704) by year 10. Benefit in cirrhotic patients was demonstrated when using the GAG‐HCC and CU‐HCC score, with the SIR at year 10 being 0.38 (95% CI 0.259‐0.544) and 0.46 (95% CI 0.314‐0.659), respectively. The cumulative rate of HBsAg seroclearance was 5.2%. HBsAg level at third year of treatment and baseline‐to‐3‐year percentage reduction was predictive of subsequent HBsAg seroclearance. In conclusion, long‐term entecavir therapy was associated with significant reduction in the risk of HCC in the real world. However, HBsAg seroclearance rate remained low. Additional therapy may be considered in patients with adverse predictive factors for subsequent HBsAg seroclearance. 相似文献
52.
53.
54.
55.
Nunobe S Kiyokawa T Hatao F Wada I Shimizu N Nomura S Mise Y Sugawara Y Kokudo N Seto Y 《Hepato-gastroenterology》2012,59(113):307-309
Systemic chemotherapy is the treatment recommended for prolonged survival in cases of metastatic gastric cancer. There have been a number of clinical reports of surgical resection of liver metastasis in selected patients with gastric cancer. Here, we report on a case of treatment of far advanced gastric cancer with synchronous multiple liver metastases with prompt S-1 in combination with fractional cisplatin sandwiched between twostage surgery. Metastases including peritoneal dissemination and extensive lymph node involvement were absent so it was feasible to completely remove all of the macroscopic liver metastases. Each step of the chemotherapy progressed satisfactorily and histological examination after the hepatectomy yielded a pathologically complete response of liver metastases from the gastric cancer. This strategy provides a promising treatment for far advanced gastric cancer with a limited number of synchronous liver metastases. The referral to surgical oncology is a crucial step for the documentation of pathological complete response. 相似文献
56.
57.
58.
59.
Ryosuke Kita Mika Seto Hiromasa Takahashi Yumiko Sakamoto Toshihiro Kikuta 《Oral Science International》2013,10(1):40-43
Wiskott–Aldrich syndrome (WAS) is a condition with variable expression, which causes persistent thrombocytopenia and, in its complete form, also causes small platelets and humoral immunodeficiency. A 14-year-old boy, diagnosed with WAS but never treated, presented with symptoms of heart and renal failure. His right buccal region was swollen and his right first molar showed a cyst-like image on dental X-ray films. The boy's symptoms were attributed to an infected cyst, greatly aggravated by WAS-related immunodeficiency. The boy was sedated and the affected tooth and cyst were enucleated. Invasive treatment was safely achieved by paying close attention to whole-body management. 相似文献
60.
Matsui S Taki H Shinoda K Suzuki K Hayashi R Tobe K Tokimitsu Y Ishida M Fushiki H Seto H Fukuoka J Ishizawa S 《Modern rheumatology / the Japan Rheumatism Association》2012,22(1):31-39
'Immunoglobulin G4 (IgG4)-related disease' is a new clinical concept of multi-organ diseases, with Mikulicz's disease (MD) being a clinical phenotype of IgG4-related disease. To clarify the clinical characteristics of respiratory involvement associated with IgG4-related MD, we retrospectively assessed 25 patients with MD, 11 (44%) of whom had allergic symptoms, and 7 (28%) of whom complained of respiratory problems. Thirteen patients (52%) presented with pulmonary and/or mediastinal lesions (P-MD) on chest computed tomography (CT), and 11 (44%) had lesions limited to the lacrimal and/or salivary glands (L-MD). Mean serum total protein, IgG, and IgG4 concentrations were significantly higher and CH50 was significantly lower in the P-MD than in the L-MD group. Immune complex was present only in the P-MD group. Chest CT images showed bronchial wall thickening, consolidation, nodule(s), interlobular thickening, ground glass opacity, pleural thickening/effusion, and mediastinal lymphadenopathy. Five of seven patients who underwent histological examination of the lungs had abundant IgG4-positive plasma cell infiltrates (IgG4/IgG-positive plasma cells >40%), but the other two did not. These findings suggest that respiratory lesions are not rare in patients with IgG4-related MD, and that they present with various manifestations. IgG4-related MD should be differentiated from similar diseases, such as sarcoidosis, bronchial asthma, Sj?gren's syndrome, and malignant lymphoma. 相似文献